UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.309

Sortiert nach

Andexanet for Factor Xa Inhibitor–Associated Acute Intracerebral Hemorrhage

The New England journal of medicine, 2024-05, Vol.390 (19), p.1745-1755

2024

Link zum Volltext

Verfügbarkeit prüfen

Effect of on-demand vs continuous prescription of proton pump inhibitors on symptom burden and quality of life: results of a real-world randomized controlled trial in primary care patients with gastroesophageal reflux disease

Annals of medicine (Helsinki), 2024-12, Vol.56 (1), p.2354683-2354683

2024

Link zum Volltext

Verfügbarkeit prüfen

Proton pump inhibitors and gastrointestinal symptoms among patients with COVID-19 infection

Annals of medicine (Helsinki), 2024-12, Vol.56 (1), p.2355581-2355581

2024

Link zum Volltext

Verfügbarkeit prüfen

NRS2002 score as a prognostic factor in solid tumors treated with immune checkpoint inhibitor therapy: a real-world evidence analysis

Cancer biology & therapy, 2024-12, Vol.25 (1), p.2358551-2358551

2024

Link zum Volltext

Verfügbarkeit prüfen

A nomogram based on the SII3 and clinical indicators predicts survival in patients with nasopharyngeal carcinoma treated with PD-1 inhibitors

Medicine (Baltimore), 2024-05, Vol.103 (19), p.e38017-e38017

2024

Link zum Volltext

Verfügbarkeit prüfen

Value of combining biological age with assessment of individual frailty to optimize management of cancer treated with targeted therapies: model of chronic myeloid leukemia treated with tyrosine kinase inhibitors (BIO-TIMER trial)

BMC cancer, 2024-05, Vol.24 (1), p.661-661

2024

Link zum Volltext

Verfügbarkeit prüfen

The later-line efficacy and safety of immune checkpoint inhibitors plus anlotinib in EGFR-mutant patients with EGFR-TKI-resistant NSCLC: a single-center retrospective study

Cancer Immunology, Immunotherapy : CII, 2024-05, Vol.73 (7), p.134-134

2024

Link zum Volltext

Verfügbarkeit prüfen

Beneficial effects of maintaining liver function during hepatic arterial infusion chemotherapy combined with tyrosine kinase and programmed cell death protein-1 inhibitors on the outcomes of patients with unresectable hepatocellular carcinoma

BMC cancer, 2024-05, Vol.24 (1), p.588-588

2024

Link zum Volltext

Verfügbarkeit prüfen

Aperiodic components of local field potentials reflect inherent differences between cortical and subcortical activity

Cerebral cortex (New York, N.Y. 1991), 2024-05, Vol.34 (5)

2024

Link zum Volltext

Verfügbarkeit prüfen

Erythema dyschromicum perstans-like eruptions induced by epidermal growth factor receptor inhibitors in patients with lung cancer

Supportive care in cancer, 2024-06, Vol.32 (6), p.354-354

2024

Link zum Volltext

Verfügbarkeit prüfen

The efficacy and safety of dalpiciclib, a cyclin-dependent kinase 4/6 inhibitor, in patients with advanced head and neck mucosal melanoma harboring CDK4 amplification

BMC medicine, 2024-05, Vol.22 (1), p.215-215

2024

Link zum Volltext

Verfügbarkeit prüfen

The effect of inhaler prescription on the development of lung cancer in COPD: a nationwide population-based study

Respiratory research, 2024-05, Vol.25 (1), p.229-229

2024

Link zum Volltext

Verfügbarkeit prüfen

Nomograms based on ratio indexes to predict severity and prognosis in immune checkpoint inhibitors-related myocarditis: a retrospective analysis

Journal of cancer research and clinical oncology, 2024-05, Vol.150 (5), p.277-277

2024

Link zum Volltext

Verfügbarkeit prüfen

The efficiency and safety of temozolomide and PD-1/L1 inhibitors in pretreated NSCLC with brain metastasis: a retrospective cohort

Journal of cancer research and clinical oncology, 2024-05, Vol.150 (5), p.271-271

2024

Link zum Volltext

Verfügbarkeit prüfen

PDE5 inhibition mitigates heart failure in hyperlipidemia

Biomedicine & pharmacotherapy, 2024-06, Vol.175, p.116710-116710, Article 116710

2024

Link zum Volltext

Verfügbarkeit prüfen

Nucleobindin 2 inhibits senescence in gastric carcinoma

Scientific reports, 2024-05, Vol.14 (1), p.11261-11261

2024

Link zum Volltext

Verfügbarkeit prüfen

A Novel JAK1 Inhibitor SHR0302 Combined With Prednisone for First-Line Treatment of Chronic Graft-Versus-Host Disease: A Phase I Clinical Trial

Cell transplantation, 2024-01, Vol.33, p.9636897241254678-9636897241254678

2024

Link zum Volltext

Verfügbarkeit prüfen

Activation of the cGMP/PKG/ERK signaling pathway associated with PDE5Is inhibits fibroblast activation by downregulating autophagy in early progressive benign prostatic hyperplasia

World journal of urology, 2024-05, Vol.42 (1), p.333-333

2024

Link zum Volltext

Verfügbarkeit prüfen

Targeting BTLA with the peptide inhibitor HVEM(14-39) – A new way to restore the activity of T cells in melanoma

Biomedicine & pharmacotherapy, 2024-06, Vol.175, p.116675-116675, Article 116675

2024

Link zum Volltext

Verfügbarkeit prüfen

Development of a chemiluminescence assay for tissue plasminogen activator inhibitor complex and its applicability to gastric cancer

BMC biotechnology, 2024-05, Vol.24 (1), p.30-30

2024

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of Amyloid-β (Aβ)-Induced Cognitive Impairment and Neuroinflammation in CHI3L1 Knockout Mice through Downregulation of ERK-PTX3 Pathway

International journal of molecular sciences, 2024-05, Vol.25 (10), p.5550

2024

Link zum Volltext

Verfügbarkeit prüfen

TNF-alpha inhibitors in organ transplant recipients: a retrospective cohort study

Archives of dermatological research, 2024-05, Vol.316 (5), p.179-179

2024

Link zum Volltext

Verfügbarkeit prüfen

Apremilast Decreased Proinflammatory Cytokines and Subsequently Increased Inhibitory ones in Psoriasis: A Prospective Cohort Study

Acta dermato-venereologica, 2024-05, Vol.104, p.adv37555-adv37555

2024

Link zum Volltext

Verfügbarkeit prüfen

Widespread use of proton pump inhibitors or potassium-competitive acid blocker has changed the status of gastrointestinal bleeding in patients with ischemic heart disease: real-world data from high volume centers

BMC gastroenterology, 2024-05, Vol.24 (1), p.177-177

2024

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.309

Suche als RSS-Feed

Aktive Filter

Neu hinzugefügt... seit 30 Tagen

ThemaAged

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.288)
Mit Volltextzugriff
(1.247)

Publikationsform

Artikel
(1.309)

Sprache

Erscheinungsjahr

n.n

Thema

13 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Scientific Reports
(187)
Plos One
(105)
International Journal Of Molecular Sciences
(37)
Nature Communications
(29)
Bmc Geriatrics
(25)
Bmc Cancer
(24)
Nutrients
(24)
Bmc Public Health
(23)
Bmj Open
(22)
Medicina
(22)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(117)

Menü

Weitere Dienste

Einstellungen

Andexanet for Factor Xa Inhibitor–Associated Acute Intracerebral Hemorrhage

Single-cell transcriptomic analyses reveal distinct immune cell contributions to epithelial barrier dysfunction in checkpoint inhibitor colitis

Effect of on-demand vs continuous prescription of proton pump inhibitors on symptom burden and quality of life: results of a real-world randomized controlled trial in primary care patients with gastroesophageal reflux disease

Proton pump inhibitors and gastrointestinal symptoms among patients with COVID-19 infection

NRS2002 score as a prognostic factor in solid tumors treated with immune checkpoint inhibitor therapy: a real-world evidence analysis

A nomogram based on the SII3 and clinical indicators predicts survival in patients with nasopharyngeal carcinoma treated with PD-1 inhibitors

Value of combining biological age with assessment of individual frailty to optimize management of cancer treated with targeted therapies: model of chronic myeloid leukemia treated with tyrosine kinase inhibitors (BIO-TIMER trial)

The later-line efficacy and safety of immune checkpoint inhibitors plus anlotinib in EGFR-mutant patients with EGFR-TKI-resistant NSCLC: a single-center retrospective study

Beneficial effects of maintaining liver function during hepatic arterial infusion chemotherapy combined with tyrosine kinase and programmed cell death protein-1 inhibitors on the outcomes of patients with unresectable hepatocellular carcinoma

Aperiodic components of local field potentials reflect inherent differences between cortical and subcortical activity

Erythema dyschromicum perstans-like eruptions induced by epidermal growth factor receptor inhibitors in patients with lung cancer

The efficacy and safety of dalpiciclib, a cyclin-dependent kinase 4/6 inhibitor, in patients with advanced head and neck mucosal melanoma harboring CDK4 amplification

The effect of inhaler prescription on the development of lung cancer in COPD: a nationwide population-based study

Nomograms based on ratio indexes to predict severity and prognosis in immune checkpoint inhibitors-related myocarditis: a retrospective analysis

The efficiency and safety of temozolomide and PD-1/L1 inhibitors in pretreated NSCLC with brain metastasis: a retrospective cohort

PDE5 inhibition mitigates heart failure in hyperlipidemia

Nucleobindin 2 inhibits senescence in gastric carcinoma

A Novel JAK1 Inhibitor SHR0302 Combined With Prednisone for First-Line Treatment of Chronic Graft-Versus-Host Disease: A Phase I Clinical Trial

Activation of the cGMP/PKG/ERK signaling pathway associated with PDE5Is inhibits fibroblast activation by downregulating autophagy in early progressive benign prostatic hyperplasia

Targeting BTLA with the peptide inhibitor HVEM(14-39) – A new way to restore the activity of T cells in melanoma

Development of a chemiluminescence assay for tissue plasminogen activator inhibitor complex and its applicability to gastric cancer

Inhibition of Amyloid-β (Aβ)-Induced Cognitive Impairment and Neuroinflammation in CHI3L1 Knockout Mice through Downregulation of ERK-PTX3 Pathway

TNF-alpha inhibitors in organ transplant recipients: a retrospective cohort study

Apremilast Decreased Proinflammatory Cytokines and Subsequently Increased Inhibitory ones in Psoriasis: A Prospective Cohort Study

Widespread use of proton pump inhibitors or potassium-competitive acid blocker has changed the status of gastrointestinal bleeding in patients with ischemic heart disease: real-world data from high volume centers

Aktive Filter

Suchergebnisse filtern